ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Prostate Cancer Vaccines Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-28J7570
Home | Market Reports | Health| Men s Health
Global Prostate Cancer Vaccines Market Insights Forecast to 2028
BUY CHAPTERS

Global Prostate Cancer Vaccines Market Research Report 2025

Code: QYRE-Auto-28J7570
Report
July 2025
Pages:106
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Dendreon Corporation
Bavarian Nordic
Advantagene Inc
OncBioMune Pharmaceuticals
Advaxis Immunotherapies
SOTIO
Cleveland BioLabs, Inc.
CureVac
Mediolanum Farmaceutici
Pfizer Inc
Vaccitech
Sensei Biotherapeutics
MediGene AG
Ultimovacs
Oncovir Inc
UbiVac
Momotaro-Gene Inc.
Vaccibody AS
AlphaVax

Prostate Cancer Vaccines Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Prostate Cancer Vaccines Market

Prostate Cancer Vaccines Market

The global market for Prostate Cancer Vaccines was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Vaccines.
The Prostate Cancer Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Prostate Cancer Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prostate Cancer Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Prostate Cancer Vaccines Market Report

Report Metric Details
Report Name Prostate Cancer Vaccines Market
CAGR 5%
Segment by Type
  • Tablet
  • Injection
Segment by Application
  • Hospital
  • Clinic
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Dendreon Corporation, Bavarian Nordic, Advantagene, OncBioMune Pharmaceuticals, Advaxis immunotherapies, SOTIO, Cleveland BioLabs Inc., Curevac AG, Mediolanum Farmaceutici, Pfizer Inc., Vaccitech, Sensei Biotherapeutics, Medigene AG, Ultimovacs, Oncovir Inc., UbiVac, Momotaro-Gene Inc., Vaccibody AS, AlphaVax Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Prostate Cancer Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Prostate Cancer Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Prostate Cancer Vaccines Market report?

Ans: The main players in the Prostate Cancer Vaccines Market are Dendreon Corporation, Bavarian Nordic, Advantagene, OncBioMune Pharmaceuticals, Advaxis immunotherapies, SOTIO, Cleveland BioLabs Inc., Curevac AG, Mediolanum Farmaceutici, Pfizer Inc., Vaccitech, Sensei Biotherapeutics, Medigene AG, Ultimovacs, Oncovir Inc., UbiVac, Momotaro-Gene Inc., Vaccibody AS, AlphaVax Inc.

What are the Application segmentation covered in the Prostate Cancer Vaccines Market report?

Ans: The Applications covered in the Prostate Cancer Vaccines Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Prostate Cancer Vaccines Market report?

Ans: The Types covered in the Prostate Cancer Vaccines Market report are Tablet, Injection

Recommended Reports

Vaccine Markets

Cancer Therapeutics

Vaccine Delivery & Packaging

1 Prostate Cancer Vaccines Market Overview
1.1 Product Definition
1.2 Prostate Cancer Vaccines by Type
1.2.1 Global Prostate Cancer Vaccines Market Value Comparison by Type (2024 VS 2031)
1.2.2 Tablet
1.2.3 Injection
1.3 Prostate Cancer Vaccines by Application
1.3.1 Global Prostate Cancer Vaccines Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Prostate Cancer Vaccines Market Size Estimates and Forecasts
1.4.1 Global Prostate Cancer Vaccines Revenue 2020-2031
1.4.2 Global Prostate Cancer Vaccines Sales 2020-2031
1.4.3 Global Prostate Cancer Vaccines Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Prostate Cancer Vaccines Market Competition by Manufacturers
2.1 Global Prostate Cancer Vaccines Sales Market Share by Manufacturers (2020-2025)
2.2 Global Prostate Cancer Vaccines Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Prostate Cancer Vaccines Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Prostate Cancer Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Prostate Cancer Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Prostate Cancer Vaccines, Product Type & Application
2.7 Global Key Manufacturers of Prostate Cancer Vaccines, Date of Enter into This Industry
2.8 Global Prostate Cancer Vaccines Market Competitive Situation and Trends
2.8.1 Global Prostate Cancer Vaccines Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Prostate Cancer Vaccines Players Market Share by Revenue
2.8.3 Global Prostate Cancer Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Prostate Cancer Vaccines Market Scenario by Region
3.1 Global Prostate Cancer Vaccines Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Prostate Cancer Vaccines Sales by Region: 2020-2031
3.2.1 Global Prostate Cancer Vaccines Sales by Region: 2020-2025
3.2.2 Global Prostate Cancer Vaccines Sales by Region: 2026-2031
3.3 Global Prostate Cancer Vaccines Revenue by Region: 2020-2031
3.3.1 Global Prostate Cancer Vaccines Revenue by Region: 2020-2025
3.3.2 Global Prostate Cancer Vaccines Revenue by Region: 2026-2031
3.4 North America Prostate Cancer Vaccines Market Facts & Figures by Country
3.4.1 North America Prostate Cancer Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Prostate Cancer Vaccines Sales by Country (2020-2031)
3.4.3 North America Prostate Cancer Vaccines Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Prostate Cancer Vaccines Market Facts & Figures by Country
3.5.1 Europe Prostate Cancer Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Prostate Cancer Vaccines Sales by Country (2020-2031)
3.5.3 Europe Prostate Cancer Vaccines Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Prostate Cancer Vaccines Market Facts & Figures by Region
3.6.1 Asia Pacific Prostate Cancer Vaccines Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Prostate Cancer Vaccines Sales by Region (2020-2031)
3.6.3 Asia Pacific Prostate Cancer Vaccines Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Prostate Cancer Vaccines Market Facts & Figures by Country
3.7.1 Latin America Prostate Cancer Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Prostate Cancer Vaccines Sales by Country (2020-2031)
3.7.3 Latin America Prostate Cancer Vaccines Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Prostate Cancer Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Prostate Cancer Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Prostate Cancer Vaccines Sales by Country (2020-2031)
3.8.3 Middle East and Africa Prostate Cancer Vaccines Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Prostate Cancer Vaccines Sales by Type (2020-2031)
4.1.1 Global Prostate Cancer Vaccines Sales by Type (2020-2025)
4.1.2 Global Prostate Cancer Vaccines Sales by Type (2026-2031)
4.1.3 Global Prostate Cancer Vaccines Sales Market Share by Type (2020-2031)
4.2 Global Prostate Cancer Vaccines Revenue by Type (2020-2031)
4.2.1 Global Prostate Cancer Vaccines Revenue by Type (2020-2025)
4.2.2 Global Prostate Cancer Vaccines Revenue by Type (2026-2031)
4.2.3 Global Prostate Cancer Vaccines Revenue Market Share by Type (2020-2031)
4.3 Global Prostate Cancer Vaccines Price by Type (2020-2031)
5 Segment by Application
5.1 Global Prostate Cancer Vaccines Sales by Application (2020-2031)
5.1.1 Global Prostate Cancer Vaccines Sales by Application (2020-2025)
5.1.2 Global Prostate Cancer Vaccines Sales by Application (2026-2031)
5.1.3 Global Prostate Cancer Vaccines Sales Market Share by Application (2020-2031)
5.2 Global Prostate Cancer Vaccines Revenue by Application (2020-2031)
5.2.1 Global Prostate Cancer Vaccines Revenue by Application (2020-2025)
5.2.2 Global Prostate Cancer Vaccines Revenue by Application (2026-2031)
5.2.3 Global Prostate Cancer Vaccines Revenue Market Share by Application (2020-2031)
5.3 Global Prostate Cancer Vaccines Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Dendreon Corporation
6.1.1 Dendreon Corporation Company Information
6.1.2 Dendreon Corporation Description and Business Overview
6.1.3 Dendreon Corporation Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Dendreon Corporation Prostate Cancer Vaccines Product Portfolio
6.1.5 Dendreon Corporation Recent Developments/Updates
6.2 Bavarian Nordic
6.2.1 Bavarian Nordic Company Information
6.2.2 Bavarian Nordic Description and Business Overview
6.2.3 Bavarian Nordic Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bavarian Nordic Prostate Cancer Vaccines Product Portfolio
6.2.5 Bavarian Nordic Recent Developments/Updates
6.3 Advantagene
6.3.1 Advantagene Company Information
6.3.2 Advantagene Description and Business Overview
6.3.3 Advantagene Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Advantagene Prostate Cancer Vaccines Product Portfolio
6.3.5 Advantagene Recent Developments/Updates
6.4 OncBioMune Pharmaceuticals
6.4.1 OncBioMune Pharmaceuticals Company Information
6.4.2 OncBioMune Pharmaceuticals Description and Business Overview
6.4.3 OncBioMune Pharmaceuticals Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.4.4 OncBioMune Pharmaceuticals Prostate Cancer Vaccines Product Portfolio
6.4.5 OncBioMune Pharmaceuticals Recent Developments/Updates
6.5 Advaxis immunotherapies
6.5.1 Advaxis immunotherapies Company Information
6.5.2 Advaxis immunotherapies Description and Business Overview
6.5.3 Advaxis immunotherapies Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Advaxis immunotherapies Prostate Cancer Vaccines Product Portfolio
6.5.5 Advaxis immunotherapies Recent Developments/Updates
6.6 SOTIO
6.6.1 SOTIO Company Information
6.6.2 SOTIO Description and Business Overview
6.6.3 SOTIO Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.6.4 SOTIO Prostate Cancer Vaccines Product Portfolio
6.6.5 SOTIO Recent Developments/Updates
6.7 Cleveland BioLabs Inc.
6.7.1 Cleveland BioLabs Inc. Company Information
6.7.2 Cleveland BioLabs Inc. Description and Business Overview
6.7.3 Cleveland BioLabs Inc. Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Cleveland BioLabs Inc. Prostate Cancer Vaccines Product Portfolio
6.7.5 Cleveland BioLabs Inc. Recent Developments/Updates
6.8 Curevac AG
6.8.1 Curevac AG Company Information
6.8.2 Curevac AG Description and Business Overview
6.8.3 Curevac AG Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Curevac AG Prostate Cancer Vaccines Product Portfolio
6.8.5 Curevac AG Recent Developments/Updates
6.9 Mediolanum Farmaceutici
6.9.1 Mediolanum Farmaceutici Company Information
6.9.2 Mediolanum Farmaceutici Description and Business Overview
6.9.3 Mediolanum Farmaceutici Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Mediolanum Farmaceutici Prostate Cancer Vaccines Product Portfolio
6.9.5 Mediolanum Farmaceutici Recent Developments/Updates
6.10 Pfizer Inc.
6.10.1 Pfizer Inc. Company Information
6.10.2 Pfizer Inc. Description and Business Overview
6.10.3 Pfizer Inc. Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Pfizer Inc. Prostate Cancer Vaccines Product Portfolio
6.10.5 Pfizer Inc. Recent Developments/Updates
6.11 Vaccitech
6.11.1 Vaccitech Company Information
6.11.2 Vaccitech Description and Business Overview
6.11.3 Vaccitech Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Vaccitech Prostate Cancer Vaccines Product Portfolio
6.11.5 Vaccitech Recent Developments/Updates
6.12 Sensei Biotherapeutics
6.12.1 Sensei Biotherapeutics Company Information
6.12.2 Sensei Biotherapeutics Description and Business Overview
6.12.3 Sensei Biotherapeutics Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Sensei Biotherapeutics Prostate Cancer Vaccines Product Portfolio
6.12.5 Sensei Biotherapeutics Recent Developments/Updates
6.13 Medigene AG
6.13.1 Medigene AG Company Information
6.13.2 Medigene AG Description and Business Overview
6.13.3 Medigene AG Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Medigene AG Prostate Cancer Vaccines Product Portfolio
6.13.5 Medigene AG Recent Developments/Updates
6.14 Ultimovacs
6.14.1 Ultimovacs Company Information
6.14.2 Ultimovacs Description and Business Overview
6.14.3 Ultimovacs Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Ultimovacs Prostate Cancer Vaccines Product Portfolio
6.14.5 Ultimovacs Recent Developments/Updates
6.15 Oncovir Inc.
6.15.1 Oncovir Inc. Company Information
6.15.2 Oncovir Inc. Description and Business Overview
6.15.3 Oncovir Inc. Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Oncovir Inc. Prostate Cancer Vaccines Product Portfolio
6.15.5 Oncovir Inc. Recent Developments/Updates
6.16 UbiVac
6.16.1 UbiVac Company Information
6.16.2 UbiVac Description and Business Overview
6.16.3 UbiVac Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.16.4 UbiVac Prostate Cancer Vaccines Product Portfolio
6.16.5 UbiVac Recent Developments/Updates
6.17 Momotaro-Gene Inc.
6.17.1 Momotaro-Gene Inc. Company Information
6.17.2 Momotaro-Gene Inc. Description and Business Overview
6.17.3 Momotaro-Gene Inc. Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Momotaro-Gene Inc. Prostate Cancer Vaccines Product Portfolio
6.17.5 Momotaro-Gene Inc. Recent Developments/Updates
6.18 Vaccibody AS
6.18.1 Vaccibody AS Company Information
6.18.2 Vaccibody AS Description and Business Overview
6.18.3 Vaccibody AS Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Vaccibody AS Prostate Cancer Vaccines Product Portfolio
6.18.5 Vaccibody AS Recent Developments/Updates
6.19 AlphaVax Inc.
6.19.1 AlphaVax Inc. Company Information
6.19.2 AlphaVax Inc. Description and Business Overview
6.19.3 AlphaVax Inc. Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.19.4 AlphaVax Inc. Prostate Cancer Vaccines Product Portfolio
6.19.5 AlphaVax Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Prostate Cancer Vaccines Industry Chain Analysis
7.2 Prostate Cancer Vaccines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Prostate Cancer Vaccines Production Mode & Process Analysis
7.4 Prostate Cancer Vaccines Sales and Marketing
7.4.1 Prostate Cancer Vaccines Sales Channels
7.4.2 Prostate Cancer Vaccines Distributors
7.5 Prostate Cancer Vaccines Customer Analysis
8 Prostate Cancer Vaccines Market Dynamics
8.1 Prostate Cancer Vaccines Industry Trends
8.2 Prostate Cancer Vaccines Market Drivers
8.3 Prostate Cancer Vaccines Market Challenges
8.4 Prostate Cancer Vaccines Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Dendreon Corporation
Bavarian Nordic
Advantagene Inc
OncBioMune Pharmaceuticals
Advaxis Immunotherapies
SOTIO
Cleveland BioLabs, Inc.
CureVac
Mediolanum Farmaceutici
Pfizer Inc
Vaccitech
Sensei Biotherapeutics
MediGene AG
Ultimovacs
Oncovir Inc
UbiVac
Momotaro-Gene Inc.
Vaccibody AS
AlphaVax
List of Tables
 Table 1. Global Prostate Cancer Vaccines Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Prostate Cancer Vaccines Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Prostate Cancer Vaccines Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Prostate Cancer Vaccines Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Prostate Cancer Vaccines Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Prostate Cancer Vaccines Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Prostate Cancer Vaccines Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Prostate Cancer Vaccines Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Prostate Cancer Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Prostate Cancer Vaccines, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Prostate Cancer Vaccines, Product Type & Application
 Table 12. Global Key Manufacturers of Prostate Cancer Vaccines, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Prostate Cancer Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Vaccines as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Prostate Cancer Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Prostate Cancer Vaccines Sales by Region (2020-2025) & (K Units)
 Table 18. Global Prostate Cancer Vaccines Sales Market Share by Region (2020-2025)
 Table 19. Global Prostate Cancer Vaccines Sales by Region (2026-2031) & (K Units)
 Table 20. Global Prostate Cancer Vaccines Sales Market Share by Region (2026-2031)
 Table 21. Global Prostate Cancer Vaccines Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Prostate Cancer Vaccines Revenue Market Share by Region (2020-2025)
 Table 23. Global Prostate Cancer Vaccines Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Prostate Cancer Vaccines Revenue Market Share by Region (2026-2031)
 Table 25. North America Prostate Cancer Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Prostate Cancer Vaccines Sales by Country (2020-2025) & (K Units)
 Table 27. North America Prostate Cancer Vaccines Sales by Country (2026-2031) & (K Units)
 Table 28. North America Prostate Cancer Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Prostate Cancer Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Prostate Cancer Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Prostate Cancer Vaccines Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Prostate Cancer Vaccines Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Prostate Cancer Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Prostate Cancer Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Prostate Cancer Vaccines Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Prostate Cancer Vaccines Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Prostate Cancer Vaccines Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Prostate Cancer Vaccines Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Prostate Cancer Vaccines Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Prostate Cancer Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Prostate Cancer Vaccines Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Prostate Cancer Vaccines Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Prostate Cancer Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Prostate Cancer Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Prostate Cancer Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Prostate Cancer Vaccines Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Prostate Cancer Vaccines Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Prostate Cancer Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Prostate Cancer Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Prostate Cancer Vaccines Sales (K Units) by Type (2020-2025)
 Table 51. Global Prostate Cancer Vaccines Sales (K Units) by Type (2026-2031)
 Table 52. Global Prostate Cancer Vaccines Sales Market Share by Type (2020-2025)
 Table 53. Global Prostate Cancer Vaccines Sales Market Share by Type (2026-2031)
 Table 54. Global Prostate Cancer Vaccines Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Prostate Cancer Vaccines Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Prostate Cancer Vaccines Revenue Market Share by Type (2020-2025)
 Table 57. Global Prostate Cancer Vaccines Revenue Market Share by Type (2026-2031)
 Table 58. Global Prostate Cancer Vaccines Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Prostate Cancer Vaccines Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Prostate Cancer Vaccines Sales (K Units) by Application (2020-2025)
 Table 61. Global Prostate Cancer Vaccines Sales (K Units) by Application (2026-2031)
 Table 62. Global Prostate Cancer Vaccines Sales Market Share by Application (2020-2025)
 Table 63. Global Prostate Cancer Vaccines Sales Market Share by Application (2026-2031)
 Table 64. Global Prostate Cancer Vaccines Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Prostate Cancer Vaccines Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Prostate Cancer Vaccines Revenue Market Share by Application (2020-2025)
 Table 67. Global Prostate Cancer Vaccines Revenue Market Share by Application (2026-2031)
 Table 68. Global Prostate Cancer Vaccines Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Prostate Cancer Vaccines Price (US$/Unit) by Application (2026-2031)
 Table 70. Dendreon Corporation Company Information
 Table 71. Dendreon Corporation Description and Business Overview
 Table 72. Dendreon Corporation Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Dendreon Corporation Prostate Cancer Vaccines Product
 Table 74. Dendreon Corporation Recent Developments/Updates
 Table 75. Bavarian Nordic Company Information
 Table 76. Bavarian Nordic Description and Business Overview
 Table 77. Bavarian Nordic Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Bavarian Nordic Prostate Cancer Vaccines Product
 Table 79. Bavarian Nordic Recent Developments/Updates
 Table 80. Advantagene Company Information
 Table 81. Advantagene Description and Business Overview
 Table 82. Advantagene Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Advantagene Prostate Cancer Vaccines Product
 Table 84. Advantagene Recent Developments/Updates
 Table 85. OncBioMune Pharmaceuticals Company Information
 Table 86. OncBioMune Pharmaceuticals Description and Business Overview
 Table 87. OncBioMune Pharmaceuticals Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. OncBioMune Pharmaceuticals Prostate Cancer Vaccines Product
 Table 89. OncBioMune Pharmaceuticals Recent Developments/Updates
 Table 90. Advaxis immunotherapies Company Information
 Table 91. Advaxis immunotherapies Description and Business Overview
 Table 92. Advaxis immunotherapies Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Advaxis immunotherapies Prostate Cancer Vaccines Product
 Table 94. Advaxis immunotherapies Recent Developments/Updates
 Table 95. SOTIO Company Information
 Table 96. SOTIO Description and Business Overview
 Table 97. SOTIO Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. SOTIO Prostate Cancer Vaccines Product
 Table 99. SOTIO Recent Developments/Updates
 Table 100. Cleveland BioLabs Inc. Company Information
 Table 101. Cleveland BioLabs Inc. Description and Business Overview
 Table 102. Cleveland BioLabs Inc. Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Cleveland BioLabs Inc. Prostate Cancer Vaccines Product
 Table 104. Cleveland BioLabs Inc. Recent Developments/Updates
 Table 105. Curevac AG Company Information
 Table 106. Curevac AG Description and Business Overview
 Table 107. Curevac AG Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Curevac AG Prostate Cancer Vaccines Product
 Table 109. Curevac AG Recent Developments/Updates
 Table 110. Mediolanum Farmaceutici Company Information
 Table 111. Mediolanum Farmaceutici Description and Business Overview
 Table 112. Mediolanum Farmaceutici Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Mediolanum Farmaceutici Prostate Cancer Vaccines Product
 Table 114. Mediolanum Farmaceutici Recent Developments/Updates
 Table 115. Pfizer Inc. Company Information
 Table 116. Pfizer Inc. Description and Business Overview
 Table 117. Pfizer Inc. Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Pfizer Inc. Prostate Cancer Vaccines Product
 Table 119. Pfizer Inc. Recent Developments/Updates
 Table 120. Vaccitech Company Information
 Table 121. Vaccitech Description and Business Overview
 Table 122. Vaccitech Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Vaccitech Prostate Cancer Vaccines Product
 Table 124. Vaccitech Recent Developments/Updates
 Table 125. Sensei Biotherapeutics Company Information
 Table 126. Sensei Biotherapeutics Description and Business Overview
 Table 127. Sensei Biotherapeutics Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Sensei Biotherapeutics Prostate Cancer Vaccines Product
 Table 129. Sensei Biotherapeutics Recent Developments/Updates
 Table 130. Medigene AG Company Information
 Table 131. Medigene AG Description and Business Overview
 Table 132. Medigene AG Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Medigene AG Prostate Cancer Vaccines Product
 Table 134. Medigene AG Recent Developments/Updates
 Table 135. Ultimovacs Company Information
 Table 136. Ultimovacs Description and Business Overview
 Table 137. Ultimovacs Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Ultimovacs Prostate Cancer Vaccines Product
 Table 139. Ultimovacs Recent Developments/Updates
 Table 140. Oncovir Inc. Company Information
 Table 141. Oncovir Inc. Description and Business Overview
 Table 142. Oncovir Inc. Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Oncovir Inc. Prostate Cancer Vaccines Product
 Table 144. Oncovir Inc. Recent Developments/Updates
 Table 145. UbiVac Company Information
 Table 146. UbiVac Description and Business Overview
 Table 147. UbiVac Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. UbiVac Prostate Cancer Vaccines Product
 Table 149. UbiVac Recent Developments/Updates
 Table 150. Momotaro-Gene Inc. Company Information
 Table 151. Momotaro-Gene Inc. Description and Business Overview
 Table 152. Momotaro-Gene Inc. Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Momotaro-Gene Inc. Prostate Cancer Vaccines Product
 Table 154. Momotaro-Gene Inc. Recent Developments/Updates
 Table 155. Vaccibody AS Company Information
 Table 156. Vaccibody AS Description and Business Overview
 Table 157. Vaccibody AS Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. Vaccibody AS Prostate Cancer Vaccines Product
 Table 159. Vaccibody AS Recent Developments/Updates
 Table 160. AlphaVax Inc. Company Information
 Table 161. AlphaVax Inc. Description and Business Overview
 Table 162. AlphaVax Inc. Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 163. AlphaVax Inc. Prostate Cancer Vaccines Product
 Table 164. AlphaVax Inc. Recent Developments/Updates
 Table 165. Key Raw Materials Lists
 Table 166. Raw Materials Key Suppliers Lists
 Table 167. Prostate Cancer Vaccines Distributors List
 Table 168. Prostate Cancer Vaccines Customers List
 Table 169. Prostate Cancer Vaccines Market Trends
 Table 170. Prostate Cancer Vaccines Market Drivers
 Table 171. Prostate Cancer Vaccines Market Challenges
 Table 172. Prostate Cancer Vaccines Market Restraints
 Table 173. Research Programs/Design for This Report
 Table 174. Key Data Information from Secondary Sources
 Table 175. Key Data Information from Primary Sources
 Table 176. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Prostate Cancer Vaccines
 Figure 2. Global Prostate Cancer Vaccines Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Prostate Cancer Vaccines Market Share by Type: 2024 & 2031
 Figure 4. Tablet Product Picture
 Figure 5. Injection Product Picture
 Figure 6. Global Prostate Cancer Vaccines Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Prostate Cancer Vaccines Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Others
 Figure 11. Global Prostate Cancer Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Prostate Cancer Vaccines Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Prostate Cancer Vaccines Sales (2020-2031) & (K Units)
 Figure 14. Global Prostate Cancer Vaccines Average Price (US$/Unit) & (2020-2031)
 Figure 15. Prostate Cancer Vaccines Report Years Considered
 Figure 16. Prostate Cancer Vaccines Sales Share by Manufacturers in 2024
 Figure 17. Global Prostate Cancer Vaccines Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Prostate Cancer Vaccines Players: Market Share by Revenue in Prostate Cancer Vaccines in 2024
 Figure 19. Prostate Cancer Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Prostate Cancer Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Prostate Cancer Vaccines Sales Market Share by Country (2020-2031)
 Figure 22. North America Prostate Cancer Vaccines Revenue Market Share by Country (2020-2031)
 Figure 23. United States Prostate Cancer Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Prostate Cancer Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Prostate Cancer Vaccines Sales Market Share by Country (2020-2031)
 Figure 26. Europe Prostate Cancer Vaccines Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Prostate Cancer Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Prostate Cancer Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Prostate Cancer Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Prostate Cancer Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Prostate Cancer Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Prostate Cancer Vaccines Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Prostate Cancer Vaccines Revenue Market Share by Region (2020-2031)
 Figure 34. China Prostate Cancer Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Prostate Cancer Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Prostate Cancer Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Prostate Cancer Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Prostate Cancer Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Prostate Cancer Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Prostate Cancer Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Prostate Cancer Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Prostate Cancer Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Prostate Cancer Vaccines Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Prostate Cancer Vaccines Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Prostate Cancer Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Prostate Cancer Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Prostate Cancer Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Prostate Cancer Vaccines Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Prostate Cancer Vaccines Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Prostate Cancer Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Prostate Cancer Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Prostate Cancer Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Prostate Cancer Vaccines by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Prostate Cancer Vaccines by Type (2020-2031)
 Figure 55. Global Prostate Cancer Vaccines Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Prostate Cancer Vaccines by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Prostate Cancer Vaccines by Application (2020-2031)
 Figure 58. Global Prostate Cancer Vaccines Price (US$/Unit) by Application (2020-2031)
 Figure 59. Prostate Cancer Vaccines Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Prostate Cancer Therapeutics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Prostate Cancer Diagnostics and Therapy Market Research Report 2024
Global Advanced Prostate Cancer Drug Market Research Report 2025
Prostate Cancer Treatment Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Tumor Immunotherapy Market
Global Prostate Cancer Diagnosis and Therapy Market Research Report 2024
Cancers Immunotherapy Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vaccine Administration Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Influenza A Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vaccine Combinations Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vaccines Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Therapeutic BCG Vaccines Market Insights Forecast to 2030
Cancer Therapeutics and Biotherapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Preventable Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vaccine Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Plant based Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Vaccine Particulate Adjuvants Market Research Report 2025
Pediatric Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Vaccine Digital Data Logger Market Insights Forecast to 2030
Clinical Trials of Drugs and Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions